Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Kumi Abe-Sato
Institution:
Taisho Pharmaceutical (Japan)
Observed institution:
Taisho Pharmaceutical (Japan)
ORCID:
0000-0002-2225-0516
Observed ORCID:
0000-0002-2225-0516
OpenAlex ID:
A5064940305
Discovery of novel indole derivatives as potent and selective inhibitors of proMMP-9 activation
2023
·
Rie Nishikawa-Shimono
, Motoi Kuwabara
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
13
Discovery of Highly Potent and Selective Matrix Metalloproteinase-7 Inhibitors by Hybridizing the S1′ Subsite Binder with Short Peptides
2022
·
Hideaki Tabuse
, Kumi Abe-Sato
, et al.
·
Journal of Medicinal Chemistry
·
12
Structure-Based Optimization and Biological Evaluation of Potent and Selective MMP-7 Inhibitors for Kidney Fibrosis
2023
·
Kumi Abe-Sato
, Hideaki Tabuse
, et al.
·
Journal of Medicinal Chemistry
·
7
Discovery of TP0628103: A Highly Potent and Selective MMP-7 Inhibitor with Reduced OATP-Mediated Clearance Designed by Shifting Isoelectric Points
2024
·
Yusuke Oka
, Kumi Abe-Sato
, et al.
·
Journal of Medicinal Chemistry
·
3
Show more works
View as search
Works count:
4
Citation count:
35
H-index:
3
I10-index:
2
Year
Topic
Type
